Effect of vitamin D on serum levels of CHI3L1 inflammatory factor and oxidative stress in patients with multiple sclerosis: a before-after clinical trial
To assess the effect of vitamin D on serum levels of CHI3L1 inflammatory factor and oxidative stress in patients with multiple sclerosis
Design
This is a before-after clinical trial without control group, phase III in which 35 patients with multiple sclerosis will be enrolled. Blinding is not possible in this study
Settings and conduct
This study will be performed in the Besat Hospital in Hamadan city on 35 eligible patients with multiple sclerosis. This is a before-after clinical trial therefore blinding is not possible in this study.
Participants/Inclusion and exclusion criteria
Inclusion criteria:
Age of 18 to 65 years
Women with multiple sclerosis
Exclusion criteria:
Acute infection
Diabetes
Rheumatoid diseases
Kidney dysfunction
Malabsorption
Autoimmune diseases
Intervention groups
Intervention group:
Oral vitamin D3 supplement with a dose of 50,000 units once a week for 8 weeks
Department of Epidemiology & Biostatistics Hamadan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 81 1838 0090
Email address
poorolajal@umsha.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-05-22, 1402/03/01
Expected recruitment end date
2023-07-23, 1402/05/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of vitamin D on serum levels of CHI3L1 inflammatory factor and oxidative stress in patients with multiple sclerosis: a before-after clinical trial
Public title
Effect of vitamin D on serum levels of CHI3L1 inflammatory factor and oxidative stress in patients with multiple sclerosis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age of 18 to 65 years
Women with multiple sclerosis